Stock Events

Stock Events

UNITY BIOTECHNOLOGY INC 

$0.056100
0
+$0.00+0.18% Tuesday 20:00

Statistics

Day High
0.0618
Day Low
0.0555
52W High
3.1
52W Low
0.0487
Volume
36,088
Avg. Volume
144,772
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

5NovExpected
Q1 2025
Q2 2025
Q3 2025
-0.43
-0.29
-0.14
0
Expected EPS
0
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-25.99MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Senseonics
SENS
Mkt Cap280.85M
Senseonics Holdings is involved in the development of medical devices, some of which target age-related diseases, overlapping with Unity's market.
Alnylam Pharmaceuticals
ALNY
Mkt Cap39.89B
Alnylam Pharmaceuticals works on RNAi therapeutics that can target a wide range of diseases, including those related to aging, competing with Unity's approach.
CRISPR Therapeutics
CRSP
Mkt Cap5.25B
CRISPR Therapeutics is focused on gene editing, a technology that can be applied to age-related diseases, making it a competitor in the longevity field.
Editas Medicine
EDIT
Mkt Cap500.29M
Editas Medicine operates in the gene editing space, targeting diseases that can be related to aging, thus competing with Unity's therapeutic areas.
Sarepta Therapeutics
SRPT
Mkt Cap2B
Sarepta Therapeutics focuses on precision genetic medicine, including therapies for diseases that become more prevalent with age, competing with Unity's focus.
Novartis
NVS
Mkt Cap293.94B
Novartis offers a broad range of healthcare solutions, including treatments for age-related diseases, making it a competitor in the longevity space.
Pfizer
PFE
Mkt Cap137.76B
Pfizer is a large pharmaceutical company with a diverse portfolio that includes treatments for age-related diseases, competing with Unity's focus.
Biogen
BIIB
Mkt Cap29.4B
Biogen focuses on neurodegenerative diseases, many of which are age-related, directly competing with Unity's approach to aging and disease.

About

Unity Biotechnology, Inc. is a biotechnology firm developing therapies to slow, halt, or reverse aging-related diseases with programs like senolytic candidates targeting ophthalmologic and neurologic disorders.
Show more...
CEO
Mr. Craig R. Jalbert CIRA
Employees
16
Country
United States

Listings

MU
DE
9U9.MU
STU
DE
9U9.STU

0 Comments

Share your thoughts

FAQ

What is UNITY BIOTECHNOLOGY INC stock price today?▼
The current price of UNBX is $0.06 USD — it has increased by +0.18% in the past 24 hours. Watch UNITY BIOTECHNOLOGY INC stock price performance more closely on the chart.
What is UNITY BIOTECHNOLOGY INC stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange UNITY BIOTECHNOLOGY INC stocks are traded under the ticker UNBX.
Is UNITY BIOTECHNOLOGY INC stock price growing?▼
UNBX stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year UNITY BIOTECHNOLOGY INC has showed a -46.06% decrease.
What is UNITY BIOTECHNOLOGY INC revenue for the last year?▼
UNITY BIOTECHNOLOGY INC revenue for the last year amounts to 0 USD.
What is UNITY BIOTECHNOLOGY INC net income for the last year?▼
UNBX net income for the last year is -25.99M USD.
How many employees does UNITY BIOTECHNOLOGY INC have?▼
As of July 14, 2026, the company has 16 employees.
In which sector is UNITY BIOTECHNOLOGY INC located?▼
UNITY BIOTECHNOLOGY INC operates in the Other sector.
When did UNITY BIOTECHNOLOGY INC complete a stock split?▼
UNITY BIOTECHNOLOGY INC has not had any recent stock splits.
Where is UNITY BIOTECHNOLOGY INC headquartered?▼
UNITY BIOTECHNOLOGY INC is headquartered in South San Francisco, United States.